tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Zhiqiang Shu, 18 are a BUY (72%), 7 are a HOLD (28%).
Analyst Zhiqiang Shu, currently employed carries an average stock price target met ratio of 33.33% that have a potential upside of 11.78% achieved within 46 days. Previously, Zhiqiang Shu worked at BERENBERG.
Zhiqiang Shu’s has documented 44 price targets and ratings displayed on 9 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on BPMC, Blueprint Medicines Corp at 13-Sep-2023.
Analyst best performing recommendations are on BLUE (BLUEBIRD BIO).
The best stock recommendation documented was for BLUE (BLUEBIRD BIO) at 11/12/2021. The price target of $11 was fulfilled within 6 days with a profit of $0.68 (5.82%) receiving and performance score of 9.7.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$2
$-6.5 (-76.47%)
$4
1 months 10 days ago
(15-Nov-2024)
12/14 (85.71%)
$1.68 (525.00%)
199
Buy
$0.5
$-8 (-94.12%)
$3
1 months 10 days ago
(15-Nov-2024)
4/10 (40%)
$0.18 (56.25%)
237
Hold
$4
$-4.5 (-52.94%)
$4
1 months 10 days ago
(15-Nov-2024)
5/7 (71.43%)
$3.68 (1150.00%)
213
Hold
$2
$-6.5 (-76.47%)
$3
3 months ago
(25-Sep-2024)
5/6 (83.33%)
$1.52 (316.67%)
212
Buy
$7
$-1.5 (-17.65%)
$10
1 years 13 days ago
(12-Dec-2023)
1/2 (50%)
$4.21 (150.90%)
370
What Year was the first public recommendation made by Zhiqiang Shu?
